+ All Categories
Home > Documents > Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2...

Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2...

Date post: 09-Oct-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
75
Supporting Information © Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006
Transcript
Page 1: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

Supporting Information

© Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2006

Page 2: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S1

1,3,5-Triazepan-2,6-diones as Structurally Diverse and Conformationally Constrained Dipeptide Mimetics: Identification of

Malaria Liver Stage Inhibitors from a Small Pilot Library

Gersande Léna,[a] Eliette Lallemand,[b] Anne Charlotte Gruner,[b] Joel Boeglin,[a] Solveig Roussel,[a] Arnaud-Pierre Schaffner,[a] André Aubry,[c] Jean-François Franetich,[d] Dominique Mazier,[d] Irène Landau,[e] Jean-Paul Briand,[a] Claude

Diderjean,[c] Laurent Rénia,*[b] Gilles Guichard*[a]

[a] Immunologie et Chimie Thérapeutiques (ICT), Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France; Fax: Fax: (+33)^388-610-680; E-mail:[email protected]

[b] Immunohepatology Group, Institut Cochin, Paris, France; E-mail: [email protected]

[c] LCM3B, UMR-CNRS 7036, Groupe Biocristallographie

Université Henri Poincaré, Vandoeuvre, France

[d] INSERM U511, Groupe Hospitalier Pitié-Salpêtrière,Paris, France

[e] Equipe Parasitologie Comparée et Modèles Expérimentaux USM0307, Muséum National d’Histoire Naturelle, Paris France

Page 3: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S2

Page S2, Figure S1. 1H NMR spectrum of crude TFA·H2N-Phe-gSar-COOSu (3a) in CD3CN. Page S3, Figure S2. Polymer-supported-DIPEA (PS-DIPEA) mediated cyclization of carbamates 3 Page S4, Figure S3. Illustration of polymer-supported quenching (PSQ) for removal of electrophile (BnBr) after alkylation of urea nitrogens Page S5, Figure S4. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4a Page S6, Figure S5. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4i Page S7, Figure S6. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4p Page S8, Figure S7. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 10a Page S9, Figure S8. Stability of monoalkylated 1,3,5-triazepin-2,6-dione 10a in DMSO-d6. Page S10, Figure S9. Stability of monoalkylated 1,3,5-triazepin-2,6-dione 4a in H2O. Page S11 to S72 : RP-HPLC traces, FT-IR, 1H-NMR and 13C-NMR spectra for all compounds 4-13. Page S73, Figure S10. Toxicity of the different 1,3,5-triazepin-2,6-diones towards hepatocytes in vitro

Page 4: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S3

Figure S1. 1H NMR spectrum of crude TFA·H2N-Phe-gSar-COOSu (3a) in CD3CN. Evidence for the presence of two equal populations with cis and trans conformation about the Phe-gSar peptide bond.

αCHa (Phe)

αCHb (Phe)

α1CHa (gSar)

α1CHb (gSar)

α2CHa (gSar)

α2CHb (gSar)

+H3NN

HN O

NO O

O

O

+H3NN

O

NH

O ON OO

3a trans 3a cis

Page 5: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S4

Figure S2. Polymer-supported-DIPEA (PS-DIPEA) mediated cyclization of carbamates 3

3 Xaa Xbb Yield 4 Purity by

(%) HPLC (%)

a Phe Sar 82 > 95

f Phg Sar 67 > 95

l Phe ( N Me ) Phe 69 > 98

H N

N

N O

O R 3 C H 2 C l 2 , r . t . , 2 4 h

H 2 N +

R 2

O

N R 3

R 4

N H

R 1

O

O N

O

O

3

C F 3 C O O - R 2

R 1

R 4

4 c y c l o ( X a a g X b b C O )

N

( 3 e q . )

5.0 10.0 15.0Minutes

0

50

100

150

mAU

HN

N

NH

O

O

4a

5.0 10.0 15.0Minutes

0

50

100

150

mAU

HN

N

NH

O

O

4a

5.0 10.0 15.0Minutes

0

100

200

300

400

500

mAU

5.0 10.0 15.0Minutes

0

100

200

300

400

500

mAU

HN

N

NH

O

O

4f

5.0 10.0 15.0Minutes

0.00

0.25

0.50

0.75

1.00

AU

4l

HN

N

NH

O

O

Page 6: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S5

Figure S3. Illustration of polymer-supported sequestration (PSS) for removal of electrophile (BnBr) after alkylation of urea nitrogens in 4a to give 8a.

NH

HS

N-(2-mercaptoethyl)aminomethyl PS

1.

2. filter

N

N

N

O

O6a

Br

N

N

N

O

O6a

Page 7: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S6

Figure S4. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4a (cyclo-L-Phe-gSar-CO) with representative ROE connectivities in DMSO-d6.together with minimized structure (MM2 force field)

TToottaall eenneerrggyy ((MMMM22)):: -- 00 ..5511 KKccaall//mmooll

N

N

N

O

O

H1

H4 H2

H3a

4a

H3b

H2 H1 H3a H3b

H2 / H3a

H2 / H1

Page 8: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S7

Figure S5. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4i (cyclo-L-Phe-L-gPro-CO) with representative ROE connectivities in DMSO-d6 together with minimized structure (MM2 force field)

H2 / H3 Total energy (MM2): + 4.71 kcal/mol

N

N

N

O

O

H1

H4 H2

H3

4i

H3 H2

H2 / H1

H3 / H4

H4 H1

Page 9: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S8

Figure S6. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 4p [cyclo-(D-Phe-L-gPro-CO)] with representative ROE connectivities in DMSO-d6 together with minimized structure (MM2 force field)

H5 H3

Total energy (MM2): + 8.6 kcal/mol

N

N

N

O

O

H1

H4 H2

H3

4p

H5a

H5b

H5/H3

H2/H1

H3/H4

H2 H1 H4

Page 10: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S9

Figure S7. Partial 500MHz ROESY spectrum of 1,3,5-triazepin-2,6-dione 10a with representative ROE connectivities in DMSO-d6.

αCH(Phe)/NH(Phe)

αCH(Phe)/αCHa (Sar)

αCHb (Sar)/βH (Bn)

N

N

NHb

Ha

H

O

O

βHβH

αH

10a

Page 11: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S10

Figure S8. Stability of monoalkylated 1,3,5-triazepin-2,6-dione 10a in DMSO-d6. A) Part of the 1H-NMR spectrum of 10a freshly dissolved in DMSO-d6. B) Part of the 1H-NMR spectrum of 10a after 4 years at room temperature in DMSO-d6.

Hd

ppm (t1)4.505.005.506.00

Ha

500 MHz

300 MHz

Hb Hc Hf He

N

N

N

O

O

Ha

Hb

Hd

Hc

He

Hf

10a

A

B

Page 12: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S11

Figure S9. Stability study of 1,3,5-triazepin-2,6-dione 4a in H2O. C18 RP-HPLC traces at 1h, 7days and 30 days

2.5 5.0 7.5 10.0 12.5 15.0 17.5Minutes

0.00

0.25

0.50

0.75

1.00

1.25AU

t = 1h

t = 7 d

t = 30 d

Page 13: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S12

S11-S72. RP-HPLC traces, FT-IR, 1H-NMR and 13C-NMR spectra for compounds 4,5 8-13.

Page 14: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S13

Cyclo(Phe-gSar-CO) (4a) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

40.4

45

50

55

60

65

70

75

80

85

90

95

100.0

cm-1

%T

3182.953049.29

2928.78

1651.70

1484.051453.241438.21

1396.841357.27

1275.76

1248.78

1213.90

1165.78

1127.401085.01

1043.02

945.18

911.23

838.29

782.64

742.80

700.07

3182.953049.29

2928.78

1651.70

1484.051453.241438.21

1396.841357.27

1275.76

1248.78

1213.90

1165.78

1127.401085.01

1043.02

945.18

911.23

838.29

782.64

742.80

700.07

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes -117

0 250 500 750

mAU 10.384 II+ II-

Page 15: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S14

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

20000

7.33

67.

332

7.32

87.

321

7.31

17.

306

7.27

07.

260

7.25

57.

248

7.24

17.

239

6.97

25.

293

5.21

75.

207

5.18

65.

176

4.87

54.

653

4.64

84.

642

4.63

64.

630

4.62

54.

620

4.02

54.

011

3.99

33.

979

3.37

13.

361

3.34

23.

332

3.08

1

2.83

12.

814

2.80

32.

785

1.00

0.97

1.00

0.98

1.993.25

1.00

1.00

2.98

1.03

ppm (f1)50100150

0

5000

10000

169.

938

157.

808

136.

210

129.

263

128.

948

127.

229

56.0

29

54.5

07

37.3

32

33.8

22

Page 16: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S15

Cyclo((D)Phe-gSar-CO) (4b)

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

38.9

45

50

55

60

65

70

75

80

85

90

95

98.2

cm-1

%T

3182.673049.43

2926.84

1651.99

1483.911453.36

1438.10

1396.931357.48

1275.62

1248.92

1165.67

1127.241084.91

1042.96

945.34

911.33

838.33

782.55

742.99

700.04

Page 17: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S16

ppm (t1)1.02.03.04.05.06.07.08.0

0

500

1000

1500

2000

7.33

27.

330

7.31

77.

307

7.30

37.

285

7.27

17.

265

7.25

87.

249

7.24

47.

237

7.23

5

7.01

75.

289

5.21

75.

207

5.18

65.

176

5.04

1

4.65

64.

652

4.64

54.

640

4.63

44.

628

4.62

44.

032

4.01

94.

001

3.98

83.

651

3.63

93.

626

3.37

23.

362

3.34

43.

333

3.08

02.

832

2.81

52.

801

2.78

6

1.00

1.00

3.10

1.29

1.01

0.971.02

0.86

5.32

ppm (f1)050100150200250

0

5000

10000

15000

169.

969

158.

125

136.

301

129.

247

128.

873

127.

146

55.9

79

54.4

76

37.2

0433

.778

Page 18: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S17

Cyclo(Val-gSar-CO) (4c) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

61.7

64

66

68

70

72

74

76

78

80

82

84

86

88

90

92

94

96

98

99.5

cm-1

%T

3238.60

3079.97

2961.79

1651.86

1495.96

1440.73

1397.53

1369.25

1317.961298.20

1239.02

1185.041163.56

1126.50

1078.39

996.47

928.29859.58

827.36

764.10

676.02

2926.58

2875.94

2.5 5.0 7.5 10.0 12.5 15.0 17.

5 Minutes -0.14 0.00 0.25 0.50 0.75 1.00 1.25 AU 8.50

3 II+

Page 19: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S18

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

1000

2000

3000

4000

5000

6000

7.46

47.

260

5.60

05.

593

4.94

74.

929

4.89

54.

878

4.28

44.

263

4.23

34.

211

3.90

03.

884

3.87

33.

857

3.01

0

2.14

52.

123

2.10

12.

075

2.05

32.

030

1.03

71.

015

0.99

10.

969

1.00

1.04

1.05

3.10

1.10

6.46

0.98

0.97

ppm (f1)50100150

0

5000

10000

15000

20000

25000170.

219

158.

932

77.4

2477

.000

76.5

76

60.1

9955

.969

33.6

9529

.877

19.7

53

18.4

24

Page 20: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S19

Cyclo(Leu-gSar-CO) (4d) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

26.3

30

35

40

45

50

55

60

65

70

75

80

85

90

95

99.6

cm-1

%T

3579.38

3502.26

3219.323082.56

2927.51

1646.33

1516.16

1493.00

1466.99

1445.77

1399.49

1367.46

1342.94

1301.69

1244.93

1182.64

1161.77

1134.89

1107.02

1052.24

1025.84968.36

954.04

923.03

878.93

843.73

792.56

767.91

703.47

3326.58

1676.40

2.5 5.

0 7.5 10.0 12.5 15.

0 17.5

Minutes -73 0

100 200 300 400

m AU 9.37

3 I I + I I-

Page 21: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S20

ppm (t1)5.0

0

5000

10000

7.26

0

6.85

66.

854

5.29

25.

276

5.25

95.

224

5.20

8

4.95

94.

384

4.36

7

4.09

64.

073

4.04

44.

021

3.07

51.

884

1.86

51.

858

1.83

91.

813

1.79

41.

768

1.74

81.

727

1.72

41.

701

1.48

11.

462

1.45

51.

436

1.41

71.

410

1.39

21.

344

0.96

00.

951

0.93

80.

929

1.00

0.98

0.94

0.98

0.95

2.97

2.39

1.05

6.26

ppm (f1)50100150

0

5000

10000

15000

20000

25000

30000

35000170.

675

158.

231

77.4

2477

.000

76.5

77

56.1

73

51.0

06

39.9

66

33.7

53

24.3

82

22.8

1522

.017

Page 22: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S21

Cyclo(Dap(Fmoc)-gSar-CO) (4e) :

HN

N

NH

O

O

NHFmoc

2.5 5.

0 7.5 10.

0 12.5 15.

0 17.5

Minutes -50

0 50

100 150 200 250 300

m AU 13.737 I I

+ I I

-

Page 23: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S22

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

500

1000

1500

7.81

87.

799

7.74

87.

637

7.61

87.

568

7.39

77.

379

7.34

67.

344

7.32

47.

315

7.29

77.

264

6.08

66.

054

6.04

46.

014

5.97

95.

966

5.87

25.

871

5.86

85.

863

5.85

25.

850

5.84

85.

847

5.84

55.

842

5.84

05.

837

5.83

55.

832

5.83

15.

828

5.82

45.

822

5.82

05.

440

5.43

25.

428

5.13

55.

131

5.12

35.

109

5.09

75.

084

4.50

54.

504

4.50

14.

495

4.34

34.

223

4.20

64.

191

3.99

73.

991

3.98

03.

968

3.95

93.

941

3.50

93.

489

3.46

23.

438

3.32

93.

327

3.32

53.

313

3.28

63.

278

3.26

43.

262

2.95

52.

900

2.17

02.

157

2.15

32.

098

1.93

91.

933

1.92

81.

913

1.90

91.

907

1.00

3.26

0.92

2.20

2.16

4.27

1.93

1.00

0.89

1.13

1.97

1.10

1.18

Page 24: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S23

Cyclo(Phg-gSar-CO) (4f) :

HN

N

NH

O

O

2.5 5.0 7.5 10.0 12.5 15.

0 17.5

Minutes

-0.14 0.00 0.25 0.50 0.75 1.00

AU 9.263 I I + I I

-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

46.4

50

55

60

65

70

75

80

85

90

95

98.1

cm-1

%T 3278.72

2934.92

2349.59

2334.07

1674.34

1639.75

1489.56

1443.15

1394.78

1364.93

1334.89

1290.591249.22

1196.30

1152.00

1086.56

1023.30

1003.24978.86

922.22

825.74

771.92

758.01

710.87

697.21

669.32

3108.86

2956.96

Page 25: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S24

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

1000

2000

3000

4000

5000

6000

7000

8000

7.43

87.

417

7.39

57.

369

7.35

37.

346

7.33

67.

325

7.26

0

6.99

9

6.30

46.

282

5.27

65.

253

4.57

04.

551

4.51

84.

500

3.90

53.

882

3.85

33.

830

3.02

4

1.00

0.98

2.97

1.03

0.86

0.92

4.131.07

ppm (f1)50100150

0

5000

10000

168.

891

158.

019

137.

190

128.

348

127.

444

124.

294

76.6

2876

.407

76.2

0575

.781

61.2

43

54.0

74

33.2

30

Page 26: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S25

Cyclo((2-)Nal-gSar-CO) (4g) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

62.8

64

66

68

70

72

74

76

78

80

82

84

86

88

90

92

94

96

97.2

cm-1

%T

3233.20

1658.27

1457.08

1396.24

1270.95

1239.97

1155.74

1068.42

957.88894.92

859.55

823.35

746.85

667.913058.222921.51

3402.53

1486.79

2.5 5.

0 7.5 10.0 12.

5 15.0 17.5 Minutes -0.13

0.00 0.25 0.50 0.75 1.00 A

U 12.699 I I

+ I I

-

Page 27: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S26

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

7.82

67.

806

7.79

87.

778

7.72

37.

491

7.48

47.

472

7.45

97.

452

7.38

57.

380

7.35

77.

352

7.26

0

6.57

3

5.29

65.

251

5.23

45.

199

5.18

2

4.81

84.

761

4.75

34.

744

4.73

34.

724

4.71

54.

707

4.04

14.

018

3.98

93.

966

3.54

53.

528

3.49

73.

480

3.09

5

3.01

22.

983

2.96

42.

935

1.67

2

1.00

1.00

0.931.03

0.99

2.961.03

0.92

1.001.99

1.002.98

ppm (f1)50100150

0

5000

10000

169.

922

157.

650

133.

576

133.

457

132.

504

128.

779

128.

241

127.

630

127.

586

126.

890

126.

380

125.

938

77.4

2477

.195

77.0

0076

.577

56.0

55

54.3

73

37.5

7233

.860

Page 28: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S27

Cyclo(Tic-gSar-CO) (4h) :

HN

N

N

O

O 2.5 5.0 7.5 10.0 12.5 15.0 17.5

Minutes -0.16 0.00 0.25 0.50 0.75 1.00 1.25

AU 10.911 I I

+ I I

-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

44.2

50

55

60

65

70

75

80

85

90

95

98.8

cm-1

%T

3337.043297.17

2922.13

2320.90

1651.57

1484.04

1462.66

1433.54

1370.08

1355.641344.31

1323.39

1301.99

1243.81

1157.20

1112.11

1078.701043.95

993.35972.78

896.09

864.70834.03

791.44

778.70

750.45

719.69

667.91

3078.483007.59

2956.96

1641.01

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

44.2

50

55

60

65

70

75

80

85

90

95

98.8

cm-1

%T

3337.043297.17

2922.13

2320.90

1651.57

1484.04

1462.66

1433.54

1370.08

1355.641344.31

1323.39

1301.99

1243.81

1157.20

1112.11

1078.701043.95

993.35972.78

896.09

864.70834.03

791.44

778.70

750.45

719.69

667.91

3078.483007.59

2956.96

1641.01

Page 29: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S28

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

200007.26

07.

243

7.23

67.

224

7.21

47.

207

7.19

57.

177

7.17

07.

159

7.15

07.

145

7.09

97.

078

7.05

85

.28

3

4.86

34.

844

4.81

34.

794

4.74

4

4.69

24.

555

4.54

14.

518

4.50

34.

490

4.43

84.

400

4.37

64.

349

4.32

63.

377

3.34

03.

325

3.28

83.

087

3.03

83.

024

1.001.041.021.041.03

4.101.01

1.063.620.47

GL2

55F1

ppm (f1)050100150200250

0

5000

10000

169.

984

159.

143

134.

387

134.

275

127.

634

127.

253

126.

678

125.

984

77.4

2477

.000

76.5

76

57.7

4356

.571

46.5

20

34.0

67

32.3

87

Page 30: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S29

Cyclo(Phe-gPro-CO) (4i) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

20.2

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

99.4

cm-1

%T

3196.543076.01

2961.412890.33

1713.63

1651.21

1480.751467.741451.77

1435.76

1412.38

1354.28

1335.08

1249.87

1196.83

1162.56

1124.07

1066.751031.25

1012.06970.60

933.54

917.01

903.61

849.07

779.92

746.18738.96

701.31

690.17

2.5 5.0 7.5 10.0 12.

5 15.0 17.

5 Minutes -91

0 100 200 300 400 500 600

mAU 10.911 I I + I I-

Page 31: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S30

ppm (t1)1.02.03.04.05.06.07.08.0

0

100

200

300

400

5007.35

87.

355

7.34

17.

286

7.28

27.

271

7.25

67.

205

7.20

27.

200

7.19

27.

188

6.98

36.

145

6.14

16.

139

5.75

55.

574

5.56

85.

561

4.66

94.

661

5.57

95.

556

4.68

34.

675

4.65

54.

647

3.59

73.

590

3.58

13.

574

3.56

73.

558

3.55

2

3.32

73.

274

3.26

03.

257

3.25

23.

242

3.23

43.

220

3.06

63.

054

3.03

83.

025

2.73

42.

719

2.70

62.

691

2.59

12.

507

2.50

42.

500

2.49

62.

493

2.01

42.

001

1.99

21.

989

1.98

01.

973

1.96

71.

961

1.94

71.

942

1.93

51.

927

1.92

11.

890

1.80

61.

799

1.79

21.

789

1.78

21.

775

1.23

51.

041

1.02

80.

875

0.86

1

1.00

0.97

1.012.31

1.03

0.96

0.95

0.92

0.86

1.971.900.88

2.131.88

ppm (f1)50100150

0

5000

10000

167.

753

157.

472

136.

271

129.

290

128.

935

127.

193

64.1

92

55.0

05

46.1

86

36.5

1933

.464

22.5

56

Page 32: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S31

Cyclo((2-)Nal-gPro-CO) (4j) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

46.8

50

55

60

65

70

75

80

85

90

95

98.5

cm-1

%T

3269.58

3057.39

2926.62

1650.62

1441.48

1327.84

1275.70

1244.121195.27

1181.791165.24

1143.86

1101.34

1034.21995.98

949.05

907.00862.44

826.02

791.90

750.56

739.12704.72

668.01

1461.51

2886.072951.89

3200.00

2.5 5.

0 7.5 10.0 12.5 15.0 17.5

Minutes -85 0

100 200 300 400 500 600 mAU 13.293 I I

+ I I-

Page 33: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S32

ppm (t1)5.0

0

1000

2000

3000

4000

5000

6000

7.81

57.

740

7.48

77.

480

7.46

87.

455

7.44

87.

396

7.39

17.

368

7.36

37.

260

6.53

06.

526

5.45

75.

441

5.29

6

4.95

6

4.68

64.

681

4.66

94.

660

4.65

24.

640

4.63

53.

850

3.83

63.

822

3.81

13.

798

3.78

53.

773

3.56

63.

548

3.53

13.

518

3.50

23.

493

3.48

13.

465

3.44

2

2.99

22.

963

2.94

42.

915

2.25

22.

230

2.21

82.

210

2.19

92.

178

2.16

82.

144

2.12

62.

120

2.09

92.

084

2.07

82.

073

2.05

82.

043

2.03

12.

026

1.95

01.

939

1.90

81.

897

1.88

51.

874

1.00

0.95

1.07

1.05

2.21

1.06

2.43

0.811.43

0.93

1.012.25

1.033.34

ppm (f1)50100150

0

5000

10000

15000

167.

695

157.

602

133.

725

133.

500

132.

519

128.

729

128.

316

127.

658

127.

045

126.

368

125.

931

77.4

6477

.041

76.6

17

64.2

53

54.9

39

46.2

41

36.7

12

33.3

34

22.5

89

Page 34: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S33

Cyclo(Tic-gPro-CO) (4k) :

HN

N

N

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

47.9

50

55

60

65

70

75

80

85

90

95

97.0

cm-1

%T

3221.863067.68

2966.79

1658.831636.55

1428.81

1357.481334.18

1283.17

1253.96

1188.001172.21

1145.71

1117.171099.16

1076.86

1033.30997.69

977.25

920.04893.96

872.89856.01

842.75

804.66

767.63

746.55

721.33

662.58

2916.45

3265.82

1471.62

1443.82

2.5 5.

0 7.5 10.

0 12.5 15.

0 17.5

Minutes -

0.16 0.00 0.25 0.50 0.75 1.00 1.25

AU 11.23

2 I I

+ I I-

Page 35: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S34

ppm (t1)5.0

0

5000

10000

7.24

67.

237

7.23

17.

219

7.20

87.

200

7.18

45.

615

5.60

75.

459

5.44

65.

436

5.42

75.

414

4.88

64.

836

4.59

24.

575

4.55

74.

540

4.38

84.

337

3.80

93.

786

3.76

83.

747

3.72

73.

602

3.57

93.

557

3.54

03.

517

3.37

43.

339

3.32

23.

287

3.10

63.

090

3.05

43.

037

2.68

7

2.33

62.

314

2.29

22.

272

2.25

02.

112

2.08

92.

070

2.04

82.

032

2.02

52.

135

1.99

21.

969

1.94

81.

926

1.90

51.

885

1.87

71.

870

1.85

51.

835

1.82

81.

813

1.80

71.

792

1.50

81.

459

1.41

81.

396

1.00

0.990.98

0.950.99

1.021.05

1.00

1.10

0.09

0.981.032.072.73

3.73

Page 36: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S35

Cyclo(Phe-g(N-Me)Phe-CO) (4l) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

40.3

45

50

55

60

65

70

75

80

85

90

95

98.0

cm-1

%T

3224.09

3064.18

2965.47

1652.00

1453.60

1368.87

1201.49

1145.08

1073.861046.87

909.86

846.55

747.45

698.45

3392.40

3311.39

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes -100

0 100 200 300 400 500 600 700

m AU 14.059 I I

+ I I

-

Page 37: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S36

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

10000

20000

30000

400007.

350

7.34

67.

340

7.32

77.

322

7.31

87.

311

7.29

97.

295

7.28

27.

280

7.27

57.

269

7.25

87.

253

7.24

27.

228

7.22

07.

213

7.20

27.

196

7.13

67.

122

5.70

75.

687

5.68

25.

662

5.64

15.

257

5.05

6

4.79

34.

788

4.77

54.

768

4.76

04.

748

4.74

23.

415

3.39

83.

367

3.35

0

3.09

33.

073

3.04

53.

025

3.00

92.

982

2.96

52.

851

2.84

32.

815

2.79

42.

767

1.00

1.720.95

1.01

0.98

1.573.111.34

1.0810.66

ppm (t1)50100150

0

10000

20000

30000

40000

170.

513

156.

768

136.

209

134.

659

129.

336

129.

224

129.

049

128.

715

127.

738

127.

341

63.9

20

54.5

55

37.8

9137

.468

27.0

64

Page 38: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S37

Cyclo(Phe-gHyp(Bn)-CO) (4m) :

HN

N

NH

O

O

BnO

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

39.0

45

50

55

60

65

70

75

80

85

90

95

99.1

cm-1

%T

3207.41

3064.88

2930.09

1651.88

1452.54

1409.93

1343.00

1198.071169.93

1091.541061.77

1028.81

976.99

920.09848.29

785.72

737.49

699.601484.26

2.5 5.0 7.5 10.0 12.5 15.0 17.5

Minutes -

0.12 0.00 0.25 0.50 0.75 1.00 AU 14.04

7 I I

+ I I

-

Page 39: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S38

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

500

1000

1500

2000

2500

3000

35007.35

57.

351

7.34

67.

328

7.32

27.

317

7.30

77.

276

7.26

67.

260

7.25

26.

617

5.58

75.

577

5.56

75.

556

5.60

85.

598

4.66

64.

551

4.54

34.

534

4.52

74.

513

4.48

64.

447

4.25

24.

242

4.2

31

4.21

53.

915

3.91

23.

907

3.87

03.

743

3.72

83.

701

3.68

63.

408

3.39

33.

359

3.34

4

2.89

32.

869

2.83

82.

807

2.79

02

.75

82.

747

2.62

12.

574

2.55

62.

549

2.54

42.

539

2.53

42.

526

2.52

12.

516

2.51

12.

489

2.48

12.

477

2.16

92.

016

2.00

71.

988

2.05

21.

970

1.29

71.

275

1.20

81.

232

1.18

4

1.00

1.10

0.94

1.03

2.990.91

0.99

0.90

10.47

1.150.29

0.201.18

1.49

ppm (f1)50100150

0

5000

10000

168.

378

157.

465

137.

222

136.

131

129.

227

128.

987

128.

559

128.

043

127.

759

127.

231

77.4

2477

.000

76.5

77

74.9

26

71.3

8463

.448

54.5

2850

.516

39.6

03

36.6

44

Page 40: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S39

Cyclo(Phe-gHyp-CO) (4n) : C14H17N3O3, pale brown solid, C18-RP-HPLC (A: 0.1% TFA in H2O, B: 0.08% TFA in MeCN, 0-100% B, 1.2 ml/min, 20 min): tR = 9.392 min; IR(solid): νmax (cm-1) = 3432 (OH), 3239 (NH), 3063 (Csp2), 2926 (Csp3), 1647, 1608 (CO), 1538 (C-O) ; HRMS(ESI): calculated for C14H18N3O3: 276.1348, found: 276.1341;

HN

N

NH

O

O

HO

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes -50

0 50

100 150 200 250 300 mAU 9.39

2 II+

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

60.0

62

64

66

68

70

72

74

76

78

80

82

84

86

88

90

92

94

96

98

99.9

cm-1

%T

3239.85

1647.16

1608.16

1538.88

1487.14

1465.10

1415.69

1346.22

1195.06

1169.261057.09

1029.73

990.28

921.32

850.22

787.74

749.18740.36

702.14

671.96

3432.913063.29

2926.58

Page 41: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S40

Cyclo(Ala-gTic-CO) (4o) :

HN

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

54.0

56

58

60

62

64

66

68

70

72

74

76

78

80

82

84

86

88

90

92

94

96

9899.3

cm-1

%T

3456.56

3394.78

3237.55

2926.28

1641.33

1480.13

1456.12

1379.861342.34

1315.091293.80

1237.341225.11

1207.95

1171.81

1124.10

1091.49

1059.82

1035.74

913.38

859.04

773.10757.30

722.06698.86

1726.96

2.5 5.0 7.5 10.0 12.

5 15.0 17.

5 Minutes -97

0 100 200 300 400 500 600 700

mAU 10.433 I I + I I-

Page 42: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S41

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

1000

2000

3000

4000

7.28

97.

279

7.27

57.

271

7.25

67.

245

7.23

57.

223

7.21

4

5.74

55.

732

5.04

24.

740

4.68

8

4.62

1

4.56

94.

558

4.54

94.

536

4.52

7

3.25

83.

250

3.24

33.

207

3.19

3

2.93

92.

931

2.92

32.

889

2.87

3

2.16

21.

390

1.36

8

1.00

1.04

0.97

2.98

1.91

4.55

3.36

ppm (f1)50100150

0

5000

10000

169.

726

156.

934

134.

614

131.

154

128.

044

127.

919

127.

786

126.

438

77.4

2377

.000

76.5

76

59.3

84

48.8

27

42.3

19

33.8

89

16.6

62

Page 43: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S42

Cyclo((D)Phe-gPro-CO) (4p) :

HN

N

NH

O

O

2.5 5.

0 7.5 10.

0 12.5 15.

0 17.5

Minutes -82

0 100 200 300 400 500 mAU 10.62

7 I I + I I-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.020.2

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

99.3

cm-1

%T

3240.66

2925.07

2882.82

1729.98

1669.43

1638.95

1484.43

1455.44

1402.72

1346.66

1309.12

1289.73

1246.43

1196.12

1157.00

1132.64

1093.81

1060.811029.58

995.78

905.23

850.22824.70

756.70

696.52

667.83

3331.64

Page 44: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S43

ppm (t1)1.02.03.04.05.06.07.08.0

0

100

200

300

400

500

7.29

47.

292

7.28

97.

281

7.27

87.

275

7.26

57.

263

7.23

27.

230

7.22

77.

220

7.21

57.

210

7.20

07.

178

7.17

57.

171

7.16

16.

298

6.28

6

4.92

34.

916

4.91

04.

903

3.96

93.

956

3.94

43.

931

3.51

53.

504

3.50

03.

491

3.48

13.

477

3.46

73.

278

3.26

43.

255

3.24

93.

241

3.22

6

3.06

93.

055

3.04

13.

026

2.50

42.

500

2.49

62.

493

2.06

5

2.02

42.

010

2.00

81.

999

1.99

61.

903

1.88

41.

830

1.80

61.

792

1.79

01.

670

1.65

91.

634

1.00

1.00

1.01

2.02

1.011.010.950.90

1.00

0.97

2.771.082.07

ppm (f1)50100150

0

5000

10000

167.

411

160.

674

136.

052

129.

614

128.

798

127.

384

63.8

1261

.298

46.6

9642

.162

32.6

86

21.9

09

Page 45: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S44

Cyclo(ProgVal)CO (4r) :

HN

NH

N

O

O

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

500

1000

1500

8.34

98.

334

6.73

26.

721

4.82

54.

813

4.72

04.

705

4.69

14.

839

4.79

83.

338

3.33

53.

332

3.32

63.

323

3.32

23.

318

3.31

63.

310

3.30

72.

507

2.50

42.

500

2.49

62.

493

2.25

52.

249

2.23

01.

889

1.87

91.

865

1.85

41.

827

1.81

31.

800

1.78

6

1.71

31.

711

1.70

01.

685

1.67

11.

666

2.28

82.

274

2.27

02.

263

2.26

02.

244

2.24

22.

235

2.21

70.

965

0.95

20.

942

1.14

6.43

1.07

1.12

1.03

0.96

4.76

Page 46: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S45

Cyclo(ProgLeu)CO (4s) :

HN

NH

N

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

47.4

50

55

60

65

70

75

80

85

90

95

99.2

cm-1

%T

3207.113056.09

2957.802925.30

2871.51

1689.33

1661.60

1620.30

1453.52

1386.62

1359.40

1340.271318.43

1279.831245.80

1202.74

1172.13

1136.06

1073.33

989.20

912.52

832.86

753.70

724.82695.52

1726.96

3260.75

Page 47: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S46

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

10000

20000

30000

40000

50000

6.51

96.

495

5.56

35.

548

5.13

35.

115

5.11

05.

092

4.61

44.

591

4.56

83.

559

3.53

53.

511

3.49

12.

560

2.53

82.

532

2.51

72.

510

2.49

52.

488

2.47

32.

467

2.44

52.

072

2.05

02.

029

2.00

71.

987

1.96

41.

905

1.88

61.

867

1.84

51.

831

1.82

61.

807

1.77

91.

766

1.75

41.

744

1.73

11.

708

1.68

51.

517

1.49

41.

471

0.94

70.

929

0.92

50.

908

1.00

1.03

0.97

0.98

2.09

1.15

1.523.22

2.03

6.00

Page 48: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S47

Cyclo(Pro-gVal-CO-Pro-gVal-CO) (5r)

NH

NH

NHN

HN

N

O

O

O

O

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

500

1000

1500

2000

2500

3000

4.30

94.

303

4.29

24.

286

4.23

54.

223

4.22

04.

209

3.65

43.

641

3.51

93.

516

3.51

03.

500

3.37

43.

360

3.35

63.

343

3.31

33.

310

2.27

52.

260

2.25

02.

235

2.06

22.

056

2.04

22.

036

2.03

02.

026

2.02

02.

007

1.99

31.

991

1.98

01.

967

1.96

21.

956

1.95

51.

908

1.89

71.

890

1.88

51.

013

1.00

00.

944

0.93

1

3.003.10

1.17

1.11

1.270.341.00

0.261.04

3.89

2.5 5.0 7.5 10.0 12.5 15.0 17.5

Minutes

-81 0 100 200 300 400 500

mAU 10.741 II+

Page 49: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S48

Cyclo(Pro-gLeu-CO-Pro-gLeu-CO) (5s)

NH

NH

NHN

HN

N

O

O

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

75.4

78

80

82

84

86

88

90

92

94

96

98

100.2

cm-1

%T

3313.69

2957.85

1651.841511.30

1386.70 1201.54

1172.481135.00

1057.52

919.47802.12

768.78

720.46

2870.88

Page 50: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S49

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

7.30

15.

754

5.72

35.

350

5.32

5

4.17

44.

155

4.14

74.

129

3.59

93.

591

3.56

93.

282

3.26

13.

239

3.23

22.

173

2.16

12.

135

2.00

91.

985

1.95

61.

948

1.94

01.

932

1.92

41.

892

1.87

11.

851

1.82

11.

801

1.78

11.

760

1.66

11.

639

1.61

71.

596

1.58

71.

542

1.52

01.

501

1.47

80.

954

0.94

20.

932

0.92

00.

905

0.88

3

1.00

1.02

0.97

1.19

0.95

1.36

0.98

5.76

2.75

4.78

Page 51: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S50

1,3,7-Tribenzyl-5-methyl-[1,3,5]triazepane-2,6-dione (8a) :

N

N

N

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.019.6

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100.5

cm-1

%T

3062.41

3028.972926.82

1638.35

1494.751471.91

1452.541424.30

1356.19

1251.94

1208.591177.93

1151.55

1115.801077.17

1028.62

965.93

850.33792.23

748.01731.65

696.67

1666.29

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes -

70 0

100 200 300 400 m A

U 16.825 I I

+ I I

-

Page 52: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S51

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

1000

2000

3000

4000

5000

60007.

366

7.36

17.

355

7.34

17.

317

7.30

77.

301

7.29

17.

285

7.27

77.

268

7.25

97.

246

7.24

07.

233

7.22

2

7.13

87.

133

7.11

1

5.22

94.

926

4.87

94.

774

4.72

4

4.55

74.

507

4.31

74.

267

4.16

74.

152

4.14

04.

126

4.03

23.

985

3.54

0

3.49

03.

287

3.27

23.

236

3.21

0

2.68

0

3.33

33.

318

3.19

03.

163

1.44

3

1.00

1.011.001.00

0.98

2.01

2.98

1.010.98

13.271.98

ppm (f1)50100150

0

10000

20000

30000

40000

50000

60000

70000

80000168.

984

163.

189

137.

268

136.

683

129.

761

128.

579

128.

451

128.

291

127.

911

127.

656

127.

259

126.

772

77.4

2577

.000

76.5

7566

.704

62.3

76

52.5

21

51.4

38

39.7

10

34.5

11

Page 53: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S52

5,6,8-Tribenzyl-hexahydro-3a,6,8-triaza-azulene-4,7-dione (8i) :

N

N

N

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

24.5

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100.7

cm-1

%T

3029.37

2926.23

1667.85

1634.30

1495.83

1451.48

1419.05

1351.49

1280.40

1241.90

1203.24

1156.75

1077.80

1029.26969.15

941.09902.86

846.76

821.04799.93

733.00

697.05

3488.603083.54

3058.22

2951.89

2881.01

2.5 5.0 7.5 10.0 12.

5 15.0 17.5

Minutes -0.14 0.00

0.25 0.50 0.75 1.00

AU 17.304 I I + I I

-

Page 54: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S53

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

1000

2000

3000

4000

5000

60007.31

77.

312

7.30

47

.29

67.

292

7.28

87.

278

7.27

17.

264

7.25

97.

227

7.22

37.

218

7.20

57.

125

7.11

97.

098

5.59

75.

576

5.56

75.

545

4.66

64.

617

4.52

14.

466

4.38

54.

330

4.14

24.

130

4.11

34.

101

3.72

83.

718

3.70

03.

692

3.50

73.

496

3.47

33.

433

3.38

4

3.33

33.

320

3.28

63.

274

3.10

33.

075

3.05

73.

028

2.01

31.

998

1.98

81.

967

1.86

41.

852

1.84

21.

831

1.82

11.

810

1.43

91.

432

1.30

21.

269

3.76

63.

758

3.52

9

3.45

62.

248

2.12

42.

115

2.09

32.

081

2.07

32.

066

2.05

12.

044

2.03

51.

977

1.95

61.

947

1.93

51.

916

1.90

71.

894

1.88

41.

874

1.78

81.

782

1.77

51.

772

1.76

21.

755

1.73

41.

729

1.71

91.

712

1.70

31.

696

1.69

11.

676

1.67

0

1.00

0.972.08

1.05

1.010.851.151.081.08

13.562.12

1.991.541.33

ppm (t1)50100150

0

5000

10000

15000

20000

168.

004

165.

005

139.

017

137.

807

137.

503

129.

994

128.

617

128.

576

128.

375

128.

319

127.

434

126.

975

126.

895

126.

774

77.4

2377

.000

76.5

76

71.2

05

66.1

53

53.2

93

47.6

03

46.1

0139

.733

30.7

74

21.6

71

Page 55: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S54

(7-Benzyl-3-tert-butoxycarbonylmethyl-5-methyl-2,6-dioxo-[1,3,5]triazepan-1-yl)-acetic acid tert-butyl ester (9a) :

N

N

N

O

O

O

O

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

20.0

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100.2

cm-1

%T

2976.96

2921.43

1739.55

1682.76

1637.29

1497.05

1469.75

1455.97

1437.83

1409.23

1386.14

1365.79

1285.061258.39

1225.791145.49

1079.11

1045.52

1013.27

987.85972.49

957.10

933.09921.60

892.90

844.26

794.10

776.18

751.45

728.00

698.96

3032.91

2850.63

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes -

108 0

250 500 750

m AU 16.551 I I + I I

-

Page 56: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S55

ppm (f1)5.0

0

5000

10000

15000

7.33

07.

324

7.30

67.

301

7.29

57.

288

7.27

67.

260

7.25

57.

241

7.21

75.

229

5.18

2

4.26

34.

216

4.09

84.

082

4.07

04.

054

4.04

63.

987

3.95

73.

899

3.83

93.

781

3.23

63.

223

3.19

63.

062

2.94

42.

885

1.46

61.

390

1.003.002.04

2.002.081.05

1.00

5.46

8.648.39

ppm (f1)50100150

0

5000

10000

15000

169.

169

168.

749

168.

605

161.

969

137.

173

129.

702

128.

614

127.

019

82.1

7781

.759

77.4

2377

.000

76.5

76

69.7

3965

.171

52.0

4151

.240

40.3

82

35.1

85

28.0

2227

.963

Page 57: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S56

(5-Benzyl-8-tert-butoxycarbonylmethyl-4,7-dioxo-octahydro-3a,6,8-triaza-azulen-6-yl)-acetic acid tert-butyl ester (9i) :

N N

O

O

O

O

O

O

2.5 5.

0 7.5 10.0 12.

5 15.0 17.5

Minutes -

109 0

250 500 750

mAU 17.005 I I

+ I I

-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.038.4

40

45

50

55

60

65

70

75

80

85

90

95.7

cm-1

%T

2922.23

2853.22

1739.64

1679.61

1638.23

1470.26

1442.15

1393.71

1373.811364.91

1287.40

1221.09

1146.84

1108.59

1081.57

1042.91

988.27

974.04

949.37

844.23

796.59

750.66

736.06

698.55

686.85

668.312956.96

2977.21

Page 58: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S57

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

10000

20000

30000

40000

7.31

97.

302

7.29

67.

288

7.27

87.

260

7.23

67.

228

7.21

67.

205

5.72

15.

701

5.69

35.

672

5.29

5

4.12

84.

105

4.04

64.

000

3.98

93.

977

3.95

73.

941

3.80

83.

801

3.76

53.

737

3.70

53.

599

3.57

63.

563

3.54

33.

526

3.50

33.

312

3.30

13.

266

3.25

43.

216

3.18

43.

169

3.13

72.

806

2.74

72.

318

2.29

92.

284

2.26

92.

249

2.04

01.

994

1.96

71.

947

1.93

71.

924

1.91

91.

460

1.37

61.

903

1.89

81.

891

1.87

81.

864

1.85

21.

846

1.83

31.

820

1.80

01.

662

1.00

0.93

1.831.951.02

0.91

1.95

0.96

2.91

8.448.27

5.33

ppm (t1)50100150

0

10000

20000

30000

40000

169.

216

168.

607

167.

675

163.

885

137.

677

129.

811

128.

543

126.

856

81.8

6581

.651

77.4

2477

.000

76.5

77

71.5

6769

.665

52.6

59

46.7

8046

.414

40.4

67

30.9

5527

.982

21.4

07

Page 59: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S58

3,7-Dibenzyl-5-methyl-[1,3,5]triazepane-2,6-dione (10a) :

N

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

44.0

50

55

60

65

70

75

80

85

90

95.4

cm-1

%T

3199.15

3063.09

3027.39

2923.04

2853.63

1725.49

1653.06

1477.581452.45

1430.36

1398.03

1372.481354.55

1327.181289.73

1257.10

1158.35

1114.71

1076.49

1028.63996.71

951.88

927.65

905.70816.79

783.72

751.21

738.00

717.77

695.79

2956.96

3296.20

2.5 5.

0 7.5 10.0 12.5 15.

0 17.5 Minutes -0.12 0.00

0.25 0.50 0.75 1.00 AU 14.06

8 I I

+ I I

-

Page 60: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S59

ppm (t1)1.02.03.04.05.06.07.08.0

0

500

1000

7.36

27.

355

7.35

27.

349

7.34

57.

343

7.33

67.

334

7.32

97.

323

7.30

87.

305

7.29

37.

288

7.28

17.

277

7.27

27.

268

7.26

47.

260

5.15

95.

128

4.80

14.

771

4.59

04.

578

4.56

94.

560

4.41

44.

384

4.14

74.

115

3.37

33.

364

3.34

43.

336

2.84

72.

829

2.81

82.

800

2.64

8

1.00

1.02

1.981.00

1.02

1.01

1.113.01

10.07

Page 61: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S60

3-Benzyl-7-isopropyl-5-methyl-[1,3,5]triazepane-2,6-dione (10c) :

N

N

NH

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

30.9

35

40

45

50

55

60

65

70

75

80

85

90

95

100101.8

cm-1

%T

3393.04

3199.433063.40

2959.96

2920.03

2850.07

1647.00

1486.39

1468.241454.94

1433.73

1397.32

1371.571352.81

1330.081287.07

1256.47

1193.60

1168.26

1155.84

1119.001102.07

1083.13

1015.31

970.89954.45

944.04935.27

856.60

842.94

819.89

775.57759.72

746.32

703.63

685.95

2.5 5.0 7.

5 10.0 12.5 15.

0 17.5

Minutes -48 0

50

100 150 200 mAU 12.453 I I +

I I-

Page 62: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S61

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

7.37

07.

357

7.34

27.

325

7.30

37.

296

7.28

47.

271

7.26

0

4.88

04.

828

4.69

14.

741

4.53

24.

482

4.45

34.

402

3.94

63.

932

3.92

43.

910

2.61

9

2.25

72.

234

2.21

22.

189

2.16

72.

144

1.07

71.

054

1.04

11.

018

1.00

1.000.991.011.99

5.02

2.95

1.06

5.90

ppm (f1)50100150

0

10000

20000

30000

40000170.

032

158.

610

137.

573

127.

919

128.

913

128.

299

77.4

9577

.072

76.6

48

61.9

3460

.659

51.5

17

34.1

9030

.989

19.7

9318

.070

Page 63: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S62

5,8-Dibenzyl-hexahydro-3a,6,8-triaza-azulene-4,7-dione (10i) :

N

N

NH

O

O

2.5 5.0 7.

5 10.0 12.5 15.

0 17.5

Minutes

-50 0

50

100 150 200 250 300 mAU 14.567 I I +

I I-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.037.2

40

45

50

55

60

65

70

75

80

85

90

95

99.7

cm-1

%T

3211.75

3029.90

2925.66

1635.68

1495.31

1446.55

1359.331295.09

1243.79

1202.63

1164.541141.08

1074.54

1029.15

967.48

943.00

826.16784.07

731.83

697.69

1663.76

Page 64: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S63

ppm (f1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

20000

25000

7.34

87.

342

7.33

07.

291

7.26

07.

255

7.23

17.

215

7.21

07.

188

5.71

35.

698

5.69

15.

676

5.12

05.

112

4.82

94.

773

4.56

6

4.51

0

4.43

74.

426

4.42

24.

412

4.40

64.

396

4.39

24.

381

3.67

73.

653

3.63

83.

630

3.61

43.

591

3.57

73.

554

3.53

23.

515

3.50

73.

492

3.45

93.

445

2.88

32.

852

2.83

52.

805

2.28

22.

267

2.26

12.

246

2.23

82.

223

2.21

62.

180

2.07

92.

060

2.02

91.

983

1.96

11.

859

1.83

71.

791

1.77

01.

764

1.000.99

1.03

1.04

0.98

10.90

3.10

0.99

0.94

2.101.10

ppm (t1)50100150

0

10000

20000

30000

40000

50000

60000

168.

351

160.

409

138.

746

136.

827

129.

572

128.

822

128.

750

127.

094

127.

058

126.

308

69.1

95

58.0

19

47.4

7745

.658

38.6

30

30.5

77

22.6

06

Page 65: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S64

(6-Benzyl-1-methyl-4,7-dioxo-[1,3,5]triazepan-3-yl)-acetic acid tert-butyl ester (11a) :

N

N

NH

O

O

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

24.7

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100.2

cm-1

%T

3221.82

3063.142975.14

2925.38

2349.95

1741.55

1678.81

1653.36

1603.91

1494.511442.48

1389.69

1365.75

1318.20

1259.97

1220.521154.71

1074.321048.08

1003.26

971.10

947.94

911.67

868.80

845.69

812.18

795.92

758.61

742.93

697.48

2.5 5.0 7.5 10.0 12.

5 15.0 17.5

Minutes -0.14 0.00 0.25 0.50 0.75 1.00

AU 13.817 I I

+ I I

-

Page 66: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S65

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

20000

25000

30000

7.33

07.

311

7.28

17.

277

7.26

0

5.46

45.

412

5.29

64.

628

4.61

84.

604

4.59

74.

588

4.58

24.

305

4.24

6

4.19

34.

141

3.88

63.

827

3.39

63.

381

3.34

83.

333

3.13

0

3.06

32.

848

2.81

82.

801

2.77

01.

453

1.00

1.94

2.10

1.12

1.043.00

1.08

9.45

5.81

ppm (f1)50100150

0

5000

10000

15000169.

818

168.

913

157.

268

136.

114

129.

358

129.

030

127.

327

82.3

46

77.4

5877

.034

76.6

11

62.8

35

55.9

9951

.485

38.2

44

34.6

87

28.0

71

Page 67: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S66

(6-Isopropyl-1-methyl-4,7-dioxo-[1,3,5]triazepan-3-yl)-acetic acid tert-butyl ester (11c) :

N

N

NH

O

O

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

38.5

45

50

55

60

65

70

75

80

85

90

95

101.1

cm-1

%T

3226.15

3095.89

2921.77

2850.69

1734.66

1651.98

1478.99

1437.49

1399.951391.16

1370.57

1359.37

1309.161286.46

1258.68

1233.661154.88

1089.101012.57

980.41953.77

886.96

856.58

819.13791.58

765.42744.84

680.27658.75

3296.20

3392.40

2.5 5.0 7.

5 10.0 12.5 15.

0 17.5

Minutes

-50 0

50

100 150 200 250 mAU 12.184 I I + I I-

Page 68: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S67

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

10000

15000

20000

7.26

0

5.11

0

5.05

84.

847

4.83

4

4.49

24.

440

4.22

2

4.16

33.

973

3.95

43.

940

3.93

03.

914

3.07

42.

220

2.19

72.

174

2.15

21.

446

1.43

51.

412

1.25

81.

229

1.05

51.

031

1.00

80.

853

0.82

8

1.00

6.83

9.42

1.20

3.00

2.12

1.06

0.94

0.98

ppm (f1)50100150

0

5000

10000

15000

20000

25000

30000

35000

169.

965

168.

913

157.

873

82.1

3477

.424

77.0

0076

.576

62.8

20

61.4

16

51.3

34

34.6

5530

.604

29.6

21

28.0

0119

.731

18.0

37

Page 69: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S68

(5-Benzyl-4,7-dioxo-octahydro-3a,6,8-triaza-azulen-8-yl)-acetic acid tert-butyl ester (11i) :

N

N

NH

O

O

O

O

2.5 5.0 7.5 10.0 12.5 15.0 17.5 Minutes

-50

0 50

100 150 200 250 mAU 14.333 I I + I I

-

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.035.0

40

45

50

55

60

65

70

75

80

85

90

95

99.5

cm-1

%T

3272.68

2927.012874.37

1735.43

1705.26

1674.47

1612.74

1489.05

1451.451415.02

1391.25

1375.64

1364.30

1330.65

1282.14

1230.80

1200.22

1161.17

1147.65

1084.75

1065.34

1033.391005.10

966.90

952.51932.59

909.40

888.33

855.83

825.07795.36

758.04

739.95

722.17

710.84

693.26

669.20

3058.22

Page 70: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S69

ppm (f1)5.0

0

10000

20000

30000

40000

50000

7.36

17.

343

7.33

77.

333

7.32

57.

313

7.30

67.

295

7.28

17.

276

7.26

07.

253

5.78

65.

773

5.76

55.

752

5.29

6

4.57

94.

573

4.46

14.

452

4.44

74.

438

4.42

94.

420

4.41

54.

401

3.77

03.

710

3.67

33.

648

3.62

33.

599

3.46

83.

454

3.42

03.

407

2.85

32.

820

2.80

52.

773

2.20

92.

186

2.17

82.

164

2.15

52.

143

2.13

32.

112

2.09

62.

082

2.06

62.

055

2.0

51

2.04

22.

035

2.02

11.

993

1.98

61.

942

1.93

51.

931

1.91

71.

911

1.45

4

1.00

0.94

2.231.94

9.04

1.841.00

1.840.89

0.92

5.39

Page 71: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S70

(7-Benzyl-1-carboxymethyl-5-methyl-2,6-dioxo-[1,3,5]triazepan-3-yl)-acetic acid (12) :

N

N

N

O

O

HO

HO

O

O

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

34.9

40

45

50

55

60

65

70

75

80

85

90

95

100.6

cm-1

%T

2927.86

1713.74

1618.79

1485.50

1454.651406.54

1325.13

1180.29

1079.22

1043.731030.01

959.26

882.07

797.32

758.15

720.29

700.85

3448.102622.782531.64

2. 5. 7. 10 12 15 17 Minu - 0

1 2 3

mA

X Y 13.2115 19.5

II

Page 72: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S71

Page 73: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S72

(6-Benzyl-1-methyl-4,7-dioxo-[1,3,5]triazepan-3-yl)-acetic acid (13) :

N

N

NH

O

O

HO

O

2.5 5.

0 7.5 10.

0 12.5 15.0 17.5 Minutes

-73 0

100 200 300 400

mAU 10.351 II+

4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 650.0

52.0

54

56

58

60

62

64

66

68

70

72

74

76

78

80

82

84

86

88

90

92

94

96

98.1

cm-1

%T

3277.35

2924.15

1951.81

1702.53

1673.73

1608.55

1496.09

1454.94

1428.05

1397.70

1347.58

1312.16

1270.981256.99

1188.54

1166.00

1081.801056.41

1036.88

1000.22

962.26

929.61

878.05

861.07

800.81

761.50

751.24

724.46

698.78

658.21

2455.69

Page 74: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S73

ppm (t1)1.02.03.04.05.06.07.08.09.0

0

5000

7.35

07.

327

7.29

37.

270

7.24

47.

209

7.18

5

6.27

7

5.58

3

5.53

1

4.80

54.

785

4.76

84.

377

4.32

44.

105

4.04

6

4.00

7

3.94

93.

086

3.06

43.

039

3.01

7

2.95

02.

813

2.79

12.

766

2.74

4

2.50

62.

500

2.49

4

1.39

3

1.00

1.04

1.06

2.12

0.983.141.11

0.39

0.98

5.32

ppm (t1)50100150

0

5000

10000

15000

20000

25000

30000

35000171.

625

170.

496

156.

362

138.

049

129.

405

128.

029

126.

170

61.6

49

54.0

4850

.294

36.1

5733

.440

Page 75: Supporting Information · 2006. 11. 7. · S3 Figure S1.1H NMR spectrum of crude TFA·H 2 N-Phe-gSar-COOSu (3a) in CD3 CN. Evidence for the presence of two equal populations with

S74

Figure S10. Toxicity of the different 1,3,5-triazepin-2,6-diones towards hepatocytes in vitro. compounds were added at various concentrations to primary hepatocyte cultures and were incubated for 48 hours. Control wells were incubated with medium alone and values are shown for the different concentrations for comparative purpose. Toxicity was evaluated with a MTT assay, which determines mitochondrial activity. Live cells which possess active mitochondrial metabolized MTT into a formazan dye. The amount of formazan dye is detected by spectroscopy. Data are mean of duplicates and are presented in arbitrary units of optical density.


Recommended